2023 AAPM Innovation Challenge
We're thrilled to announce that AlgometRx was named a finalist of the recent American Academy of Pain Medicine and MIT Hacking Medicine...
top of page
BRINGING OBJECTIVITY AND PRECISION TO PAIN MANAGEMENT
About
ABOUT ALGOMETRX
OUR TECHNOLOGY
The AlgometRx Nociometer® enables a fundamental paradigm shift in pain assessment and analgesic prescribing. Our novel technology and algorithms analyze pupil dilation in response to neuroselective stimulation to formulate a nociceptive profile. This new construct is used to characterize pain type, intensity and assess the pharmacodynamic impact of analgesics. This transformative platform technology can be applied to any population.
The Team
OUR TEAM
Julia Finkel, MD
Founder & Chief Scientific Advisor
Kevin Jackson
Chief Operating Officer
David Gross, MSEE
Chairman, Board of Directors
David Heller, MBA
Board of Directors
OUR COLLABORATORS
Contact
STAY IN TOUCH
bottom of page